| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 01/01/2002 | CA2093789C Bi-aromatic compounds and their use in human and veterinary medicine and in cosmetic preparations |
| 01/01/2002 | CA2030999C Process for producing 1,4-butanediol and tetrahydrofuran |
| 12/27/2001 | WO2001098310A1 Novel chromophores for polymeric thin films and optical waveguides and devices comprising the same |
| 12/27/2001 | WO2001098292A1 Novel electro-optic chromophore bridge compounds and donor-bridge compounds for polymeric thin film waveguides |
| 12/27/2001 | WO2001098287A1 Novel electron acceptors for polymeric thin film waveguide media |
| 12/27/2001 | WO2001098262A1 Amidine derivatives as selective antagonists of nmda receptors |
| 12/27/2001 | WO2001098248A2 Hiv integrase inhibitors |
| 12/27/2001 | WO2001098238A2 Catalytic hydrogenation of ketones and aldehydes |
| 12/27/2001 | WO2001097810A2 Use of therapeutic benzamide derivatives |
| 12/27/2001 | WO2001097806A1 Cox-2 inhibitors and the prevention of the side effects of radiation therapy |
| 12/27/2001 | WO2001051448A3 Method of gas phase catalytic oxidation to give maleic acid anhydride |
| 12/27/2001 | WO2001047877A3 Process for the preparation of pure citalopram |
| 12/27/2001 | WO2001047564A3 Labelled ascorbic acid derivatives |
| 12/27/2001 | WO2001045483A3 Method for the preparation of pure citalopram |
| 12/27/2001 | WO2001028979A3 Inhibitors of neuraminidases |
| 12/27/2001 | WO2000064864A9 N-protected amines and their use as prodrugs |
| 12/27/2001 | US20010056404 Information providing apparatus and method, information processing apparatus and method, program storage medium, program, and information providing system |
| 12/27/2001 | US20010056194 Useful as chemical intermediate for citalopram which is an antidepressant; pollution control |
| 12/27/2001 | US20010056107 Cyano and carboxy derivatives of substituted styrenes are inhibitors of tumor necrosis factor alpha , nuclear factor kappa B, and phosphodiesterase and can be used to treat cachexia, endotoxic shock, inflammatory conditions etc. |
| 12/27/2001 | US20010056100 Carboxylic acid or tetrazole derivatives containing carbamate groups are useful for treating the conditions associated with the urinary tract, pain, inflammation, respiratory states, edema formation of hypotensive vascular diseases |
| 12/27/2001 | US20010056096 Administering to a patient suffering from hypercholesterolemia, hyperlipedimea and other metabolic disorders an effective amount of hydrozone, oxime or imine derivatives |
| 12/27/2001 | US20010054207 p-aminophenol derivative compounds and dye compositions containing same |
| 12/27/2001 | CA2412985A1 Hiv integrase inhibitors |
| 12/27/2001 | CA2412362A1 Cox-2 inhibitors and the prevention of the side effects of radiation therapy |
| 12/27/2001 | CA2411963A1 Novel chromophores for polymeric thin films and optical waveguides and devices comprising the same |
| 12/27/2001 | CA2408412A1 Catalytic hydrogenation of ketones and aldehydes |
| 12/26/2001 | CN1327953A Process for treating waste liquid of furaldehyde and recovering butyl acetate, ammonium sulfate, ammonium acetate, acetamide and acetonitrile |
| 12/25/2001 | US6333425 Ionic compounds derived from malononitrile in which anionic charge is delocalized; excellent properties of solubility and dissociation |
| 12/25/2001 | US6333346 Aminofuranoneureas or thioureas 4-amino-2(5h)-thiophenones as antitumor agents |
| 12/25/2001 | US6333329 Useful for treatment and/or prevention of neuropsychological disorders including schizophrenia, mania, dementia, depression, anxiety, compulsive behavior, drug abuse, parkinson-like motor disorders and motion disorders |
| 12/22/2001 | CA2312252A1 5,6,7-trinor-4, 8-inter-m-phenylene pgi2 derivative and medicine containing the same |
| 12/20/2001 | WO2001096326A1 Alpha-phenylsulphinyl-alpha-halogeno-butyrolactone and halogeno-2-buten-2-olide-4 compounds useful for preparing halogeno-2-oxymethyl-4-furanone(4h) |
| 12/20/2001 | WO2001096325A1 Process for the preparation of saturated cyclic ethers |
| 12/20/2001 | WO2001096305A1 Serine protease inhibitors |
| 12/20/2001 | WO2001096285A1 Beta-amino acid nitrile derivatives |
| 12/20/2001 | WO2001096283A2 Hiv integrase inhibitors |
| 12/20/2001 | WO2001095905A1 Inhibitor for enzyme having two divalent metal ions as active centers |
| 12/20/2001 | WO2001056554A3 Use of retinoid-type compounds as antibacterial agents |
| 12/20/2001 | WO2001051456A3 Antibacterial agents |
| 12/20/2001 | WO2001019770A3 Rxr modulators with improved pharmacologic profile |
| 12/20/2001 | US20010053857 Tricyclic and tetracyclic taxane intermediates |
| 12/20/2001 | US20010053793 Administering dehydroascorbic acid |
| 12/20/2001 | US20010053785 Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
| 12/20/2001 | CA2412857A1 Hiv integrase inhibitors |
| 12/19/2001 | EP1163553A1 Oxime derivatives and the use thereof as photoinitiators |
| 12/19/2001 | EP1163237A1 Amide derivatives |
| 12/19/2001 | EP1163236A1 Aromatic heterocyclic compounds as anti-inflammatory agents |
| 12/19/2001 | EP1163215A1 Amino-thio-acrylonitriles as mek inhibitors |
| 12/19/2001 | EP1163213A1 Hydroxamic and carboxylic acid derivatives |
| 12/19/2001 | EP1163208A2 Caspase inhibitors and uses thereof |
| 12/19/2001 | EP1163029A2 Nitrate esters and their use for inducing neuroprotection and cognition enhancement |
| 12/19/2001 | EP0754674B1 Novel carboxylic ester derivatives, process for producing the same, and insecticide or insectifuge containing the same |
| 12/19/2001 | EP0720605B1 Aminocyclohexylesters and uses thereof |
| 12/19/2001 | CN1327383A Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 12/19/2001 | CN1076350C Dimethylfurancarboxanilide derivative |
| 12/19/2001 | CA2350865A1 Process and catalyst for the production of .gamma.-butyrolactones |
| 12/18/2001 | US6331650 Method for manufacturing aminoalcohol |
| 12/18/2001 | US6331640 Diaminopropionic acid derivatives |
| 12/18/2001 | US6331564 Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory disease |
| 12/18/2001 | US6331563 N-Hydroxy-2-(Alkyl, Aryl, or Heteroaryl, Sulfanyl, Sulfinyl or Sulfonyl)-3-Substituted Alkyl, Aryl or Heteroarylamides as Matrix Metalloproteinase inhibitors |
| 12/18/2001 | US6331542 Protease inhibitors |
| 12/18/2001 | US6331507 Substituted aromatic thiocarboxylic acid amides and their use as herbicides |
| 12/18/2001 | CA2213815C Pyrrolidinyl hydroxamic acid compounds and their production process |
| 12/13/2001 | WO2001094543A2 Production and use of derivatized homoserine lactones |
| 12/13/2001 | WO2001094329A1 Method for the production of 2- coumarone and substituted 2-coumarones |
| 12/13/2001 | WO2001094300A1 Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament |
| 12/13/2001 | WO2001094288A2 A solvent exchange process |
| 12/13/2001 | WO2001093861A1 Tissue specific prodrug |
| 12/13/2001 | WO2001087476A8 Counterflow reactor with a bundle of contact tubes |
| 12/13/2001 | WO2001049275A3 Methods and compositions for mitigating pain using nitrate esters |
| 12/13/2001 | WO2001041709A3 Methods for treating cell death diseases and inflammation |
| 12/13/2001 | WO2001029017A3 N-SUBSTITUTED 3-AMINO-2,2-DI-C-ALKYL-1,4-BUTYROLACTONES AND 1,4-THIOBUTYROLACTONES FOR USE AS PROMOTER OF η-AMINOBUTYRIC ACID ACTIVITY AND FOR TREATING NERVOUS DISORDERS AND PREPARATION METHOD |
| 12/13/2001 | US20010051734 Methods for making 2-(omega-alkoxycarbonylalkanoyl) -4-butanolide, ester of omega-hydroxy- (omega-3) - ketoaliphatic acid, and derivatives thereof |
| 12/13/2001 | US20010051640 C7 carbamoyloxy substituted taxanes |
| 12/13/2001 | CA2409843A1 Method for the production of 2-coumarone and substituted 2-coumarones |
| 12/12/2001 | EP1162200A2 Process for producing trimellitic anhydride |
| 12/12/2001 | EP1161426A1 Process for the manufacture of furfural |
| 12/12/2001 | EP1161422A1 Amine derivatives as protease inhibitors |
| 12/12/2001 | EP1161421A1 Inhibitors of protein tyrosine phosphatase |
| 12/12/2001 | EP1161415A2 N-cyanomethylamides as protease inhibitors |
| 12/12/2001 | EP1161232A1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists |
| 12/12/2001 | EP0810201B1 Preventive/remedy for liver disease |
| 12/12/2001 | EP0748307B1 Skin lightening compositions |
| 12/12/2001 | CN1326343A Agent for lowering prolactin |
| 12/12/2001 | CN1076022C Cycloether compounds as sodium channel regulating agent |
| 12/11/2001 | US6329528 Reacting alkyl benzthioimidate or its acid addition salt with furan or thiofuran acid chloride compound to product adduct-intermediate; reacting with methylhydrazine to produce 3-(substituted phenyl)-5-thienyl or furyl)-1,2,4-triazoles |
| 12/11/2001 | US6329494 Photosensitive resin composition |
| 12/11/2001 | US6329421 Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2 |
| 12/11/2001 | US6329420 2,5 bis(1-hydroxyalkyl)tetrahydrothiopene derivatives; inhibiting polymerization or inducing depolymerization of tubulin; antiproliferation agent |
| 12/11/2001 | US6329189 Enzyme producing tartaric acid ether compound and process for producing tartaric acid ether compounds using this enzyme |
| 12/11/2001 | CA2205033C Aryloxycycloalkenyl and aryloxyiminocycloalkenylhydroxyureas as 5-lipoxygenase inhibitors |
| 12/06/2001 | WO2001092273A2 Benzenedicarboxylic acid derivatives |
| 12/06/2001 | WO2001092248A1 Catalysts and processes for the conversion of succinates to citraconates or itaconates |
| 12/06/2001 | WO2001092247A2 Preparation of 4-hydroxy-3[2h]-furanones |
| 12/06/2001 | WO2001092218A2 Polyamine analogues as therapeutic and diagnostic agents |
| 12/06/2001 | WO2001092210A1 Compounds for modulating the rage receptor |
| 12/06/2001 | WO2001028974A3 Intermediates for making a benzofuran or benzothiophene derivative nitrated in position 5 and uses thereof |
| 12/06/2001 | WO2001021605A8 Method for extracting compounds of furan lipids and polyhydroxylated fatty alcohols of avocado, composition based on said compounds and use of said compounds in therapy, cosmetics and food |
| 12/06/2001 | US20010049450 Citalopram hydrobromide crystal and method for crystallization thereof |
| 12/06/2001 | US20010049374 Amidino derivatives of quinoline and naphthalene |